ConductScience.org, home

Paper36088362

Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.

Petrosyan V and 8 others. NPJ Breast Cancer, 2022. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts. Papers, record 36088362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36088362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.
PubMed
Journal
NPJ Breast Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2026-08-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Petrosyan VVarduhihttps://orcid.org/0000-0002-5356-2002
2Dobrolecki LELacey Ehttps://orcid.org/0000-0001-6839-629X
3LaPlante ELEmily Lhttps://orcid.org/0000-0002-4044-7187
4Srinivasan RRRamakrishnan Rajaramhttps://orcid.org/0000-0001-8087-9200
5Bailey MHMatthew H
6Welm ALAlana Lhttps://orcid.org/0000-0002-1412-1351
7Welm BEBryan Ehttps://orcid.org/0000-0002-1879-6612
8Lewis MTMichael T
9Milosavljevic AAleksandarhttps://orcid.org/0000-0001-5482-2825

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U54 CA224076NCI NIH HHSUnited StatesU54CA224076PubMed and NIHNIH RePORTER
U24 CA226110NCI NIH HHSUnited StatesU24CA226110PubMedNIH RePORTER
U54 DA036134NIDA NIH HHSUnited StatesU54DA036134PubMedNIH RePORTER
U54 DA049098NIDA NIH HHSUnited StatesU54DA049098PubMedNIH RePORTER
P50 CA186784NCI NIH HHSUnited StatesP50CA186784PubMedNIH RePORTER

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123737486A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.Cancer Res2013https://conductscience.org/library/papers/23737486PubMed
230853353Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.Cancer Cell2019https://conductscience.org/library/papers/30853353PubMed
331102428Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?Cancer Sci2019https://conductscience.org/library/papers/31102428PubMed
433296659Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells.Cell Rep2020https://conductscience.org/library/papers/33296659PubMed
528025748Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Cancer Metastasis Rev2016https://conductscience.org/library/papers/28025748PubMed
630386679Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.Oncoimmunology2018https://conductscience.org/library/papers/30386679PubMed
718042719CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/18042719PubMed
810592173KEGG: kyoto encyclopedia of genes and genomes.Nucleic Acids Res2000https://conductscience.org/library/papers/10592173PubMed
922689758Xenome--a tool for classifying reads from xenograft samples.Bioinformatics2012https://conductscience.org/library/papers/22689758PubMed
1028499452Current status and perspectives of patient-derived xenograft models in cancer research.J Hematol Oncol2017https://conductscience.org/library/papers/28499452PubMed
1112631387Breast cancer cell lines: friend or foe?Breast Cancer Res2003https://conductscience.org/library/papers/12631387PubMed
1220661468Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).PLoS One2010https://conductscience.org/library/papers/20661468PubMed
1325993181Triple-negative breast cancer: immune modulation as the new treatment paradigm.Am Soc Clin Oncol Educ Book2015https://conductscience.org/library/papers/25993181PubMed
1427556158Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.BMC Genomics2016https://conductscience.org/library/papers/27556158PubMed
1522019887Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.Nat Med2011https://conductscience.org/library/papers/22019887PubMed
1623372829Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.PLoS One2013https://conductscience.org/library/papers/23372829PubMed
1725634491Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.Oncol Rep2015https://conductscience.org/library/papers/25634491PubMed
1830396909Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer.Cancer Immunol Res2018https://conductscience.org/library/papers/30396909PubMed
1931931698Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software.BMC Bioinformatics2020https://conductscience.org/library/papers/31931698PubMed
2033365025Tumor-Associated Macrophages in Tumor Immunity.Front Immunol2020https://conductscience.org/library/papers/33365025PubMed

See all 44 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42035192CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.Breast Cancer Res2026https://conductscience.org/library/papers/42035192PubMed
42023233A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.Front Immunol2026https://conductscience.org/library/papers/42023233PubMed
40801311An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.Cancer Res2025https://conductscience.org/library/papers/40801311PubMed
40710292The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer.Cells2025https://conductscience.org/library/papers/40710292PubMed
40537829Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.Breast Cancer Res2025https://conductscience.org/library/papers/40537829PubMed
40281554Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40281554PubMed
39827242Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country.Sci Rep2025https://conductscience.org/library/papers/39827242PubMed
39230699PEPerMINT: peptide abundance imputation in mass spectrometry-based proteomics using graph neural networks.Bioinformatics2024https://conductscience.org/library/papers/39230699PubMed
38821942Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.Nat Commun2024https://conductscience.org/library/papers/38821942PubMed
38641411Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.Mol Cancer Ther2024https://conductscience.org/library/papers/38641411PubMed
38289417Landscape of unconventional γδ T cell subsets in cancer.Mol Biol Rep2024https://conductscience.org/library/papers/38289417PubMed
38052483The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer.Cold Spring Harb Perspect Med2024https://conductscience.org/library/papers/38052483PubMed
37296949Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice.Cancers (Basel)2023https://conductscience.org/library/papers/37296949PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36088362

GET https://conductscience.org/api/papers/v1/36088362/references?page=2